InvestorsHub Logo
Followers 27
Posts 744
Boards Moderated 0
Alias Born 07/12/2012

Re: None

Thursday, 11/14/2013 1:59:13 PM

Thursday, November 14, 2013 1:59:13 PM

Post# of 346001
Since then, Merck KGaA has refocused its research efforts and is limiting its scope to oncology, immunology, immunotherapies and neurology, high-growth spaces the company believes can help spur an R&D turnaround.

Read more: [url]Merck KGaA says big M&A could jump-start stilted pipeline - FierceBiotech http://www.fiercebiotech.com/story/merck-kgaa-says-big-ma-could-jump-start-stilted-pipeline/2013-11-
[/url]

GLTAL!

BEST,

JOE
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News